Perispinal Etanercept to improve STroke Outcomes (PESTO) Trial
8 Relevant Documents
Perispinal Etanercept to improve STroke Outcomes (PESTO) Trial
8 Relevant Documents
8 Relevant Documents
8 Relevant Documents

1. Perispinal etanercept stroke trial design: PESTO and beyond
2. Southern Health and Disability Ethics Committee (SHDEC) September 2020 Meeting Minutes
Link: https://ethics.health.govt.nz/about/meeting-dates-venues-and-minutes/southern-minutes/
License: https://creativecommons.org/licenses/by-nc-nd/4.0/
*Search for "Perispinal" to find the relevant pages within the second document below
3. Southern Health and Disability Ethics Committee (SHDEC) 2021 Annual Report
Link: https://ethics.health.govt.nz/about/meeting-dates-venues-and-minutes/southern-minutes/
License: https://creativecommons.org/licenses/by-nc-nd/4.0/
*Search for "Perispinal" to find the relevant pages within the document below

4. FOI 26-2767 – Clinical trial grant funding - containing MRFF Grants Application Guide and Stroke Foundation CEO Letter
5. Australian New Zealand Clinical Trials Registry (ANZCTR) PESTO Trial Registration
Link: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378447&isReview=true
6. eSAP_1 - containing Protocol v1.0 (30 May 2019), Protocol v2.1 (31 May 2022), Statisticial Analysis Plan (18 Dec 2023, 31 May 2022)
Link: https://www.neurology.org/doi/10.1212/WNL.0000000000213981#supplementary-materials
7. Perispinal Etanercept to improve STroke Outcomes (PESTO): Protocol for a multicenter, international, randomized placebo-controlled trial
8. Safety and Efficacy of Perispinal Etanercept for Chronic Stroke
Link: https://www.neurology.org/doi/pdf/10.1212/WNL.0000000000213981
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.